Drug treatment of the negative symptoms of schizophrenia

被引:74
|
作者
King, DJ [1 ]
机构
[1] Queens Univ Belfast, Dept Therapeut & Pharmacol, Belfast BT9 7BL, Antrim, North Ireland
关键词
schizophrenia; negative symptoms; atypical antipsychotics; typical antipsychotics; EPS;
D O I
10.1016/S0924-977X(97)00041-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The traditional antipsychotics are generally poorly effective or ineffective against the negative symptoms of schizophrenia and are also associated with extensive side effects which can themselves cause or exacerbate secondary negative symptomatology. As well as having a low propensity to cause extrapyramidal side effects (EPS), the currently available, putative, atypical antipsychotics (clozapine, risperidone, sertindole, and olanzapine), developmental antipsychotics (zotepine, quetiapine and ziprasidone) and low doses of certain traditional antipsychotics, such as amisulpride and fluphenazine, have been reported to ameliorate negative symptoms in comparison with placebo or standard antipsychotics such as fluphenazine, haloperidol or perphenazine. To date, few trials have specifically examined primary negative symptomatology and it has been suggested that the improvements observed with these drugs may be related to decreases in positive symptoms and/or reduced sedation or extrapyramidal side effects. Although atypicality has been ascribed to 5-HT2/D-2 antagonism, the exact pharmacological mechanism(s) underlying the efficacy of the atypical antipsychotics have not been elucidated. Many of these drugs bind to multiple other receptors and/or inhibit neurotransmitter uptake and it seems probable that some of these other pharmacological properties may also contribute to their clinical features. (C) 1998 Elsevier Science B.V./ECNP.
引用
收藏
页码:33 / 42
页数:10
相关论文
共 50 条
  • [31] Treatment for Negative Symptoms in Schizophrenia: A Comprehensive Review
    Veerman, Selene R. T.
    Schulte, Peter F. J.
    de Haan, Lieuwe
    DRUGS, 2017, 77 (13) : 1423 - 1459
  • [32] EPA guidance on treatment of negative symptoms in schizophrenia
    Galderisi, S.
    Kaiser, S.
    Bitter, I
    Nordentoft, M.
    Mucci, A.
    Sabe, M.
    Giordano, G. M.
    Nielsen, M. O.
    Glenthoj, L. B.
    Pezzella, P.
    Falkai, P.
    Dollfus, S.
    Gaebel, W.
    EUROPEAN PSYCHIATRY, 2021, 64 (01)
  • [33] Treatment of negative symptoms: an unmet need of schizophrenia
    Bitter, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S124 - S124
  • [34] RESPONSE OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA TO NEUROLEPTIC TREATMENT
    SERBAN, G
    SIEGEL, S
    GAFFNEY, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1992, 53 (07) : 229 - 234
  • [35] RISPERIDONE IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA - A METAANALYSIS
    CARMAN, J
    PEUSKENS, J
    VANGENEUGDEN, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1995, 10 (04) : 207 - 213
  • [36] ADJUNCTIVE TRAZODONE IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
    DECINA, P
    MUKHERJEE, S
    BOCOLA, V
    SARACENI, F
    HADJICHRISTOS, C
    SCAPICCHIO, P
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1994, 45 (12): : 1220 - 1223
  • [37] Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia
    Buchanan, Robert W.
    Weiner, Elaine
    Kelly, Deanna L.
    Gold, James M.
    Keller, William R.
    Waltz, James A.
    McMahon, Robert P.
    Gorelick, David A.
    SCHIZOPHRENIA BULLETIN, 2015, 41 (04) : 900 - 908
  • [38] DIAGNOSTIC AND TREATMENT CHALLENGES OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    Panesar, Narinder
    Garg, Vikas
    Pai, Nagesh
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 : A46 - A47
  • [39] Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment
    Reynolds, Gavin P.
    McGowan, Olga O.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (04): : 253 - 255
  • [40] Treatment of negative symptoms in schizophrenia: a challenge for clinical research
    Andrea Schmitt
    Isabel Maurus
    Peter Falkai
    European Archives of Psychiatry and Clinical Neuroscience, 2023, 273 : 525 - 526